Merit Medical Systems Earnings & Forecasts

Merit Medical Systems (MMSI) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

四半期利益の驚きの金額

会計四半期	報告日	実質EPS	推定EPS	驚き％
Q2	Jul 30, 2026	$1.19	$0.94	26.6 %
Q1	Apr 30, 2026	$0.94	$0.81	16.1 %
Q4	Feb 24, 2026	$1.04	$0.91	14.3 %
Q3	Oct 30, 2025	$0.92	$0.79	16.5 %

Quarterly Revenue (Billions)

四半期売上高の驚きの金額

会計四半期	報告日	実際の収益	推定収益	驚き％
Q2	Jul 30, 2026	$418.84M	$405.22M	3.36 %
Q1	Apr 30, 2026	$381.88M	$377.49M	1.16 %
Q4	Feb 24, 2026	$393.94M	$390.88M	0.78 %
Q3	Oct 30, 2025	$384.16M	$371.53M	3.40 %

Merit Medical Systems Guidance

Merit Medical Systems (MMSI) は、7 30, 2026 年に fiscal year 2026 のガイダンスを最後に発表しました。同社は 1 株当たり利益を $4.25 - $4.35 の範囲と予想し、コンセンサス EPS 予想は $3.98 でした。Merit Medical Systems も、この期間の売上高を $1.63B - $1.64B の範囲と予想しました。

以前のガイダンスと比較すると、Merit Medical SystemsはEPS見通しを以前の範囲である引き上げから$4.01 - $4.15に引き上げました。売上高については、同社は売上高予測を以前の範囲である維持から$1.61B - $1.63Bに引き上げました。

Merit Medical Systemsは、24から10 26, 2022の間に7 30, 2026ガイダンスの更新を発表しました。During this period, the company raised its outlook 11 times and lowered it 4 times, providing investors with insight into management's evolving expectations.

Recent Earnings Results

Metric	Q2 '26	Q1 '26	Q4 '25	Q3 '25
Earnings Per Share (Non-GAAP)
Estimate	$0.94	$0.81	$0.91	$0.79
Actual	$1.19	$0.94	$1.04	$0.92
Surprise	+26.6%	+16.1%	+14.3%	+16.5%
Revenue
Estimate	$405.2M	$377.5M	$390.9M	$371.5M
Actual	$418.8M	$381.9M	$393.9M	$384.2M
Surprise	+3.36%	+1.16%	+0.78%	+3.40%

Analyst Estimates — Forward PeriodsSource: Wall Street consensus

Metric	Q3 '26E	Q4 '26E	Q1 '27E	Q2 '27E
Earnings Per Share (Non-GAAP)
Consensus	$1.01	$1.11	$0.89	$1.07
Revenue
Consensus	$410.4M	$424.7M	—	—

More with Benzinga EdgeGet Access

Earnings & Guidance News

These Analysts Increase Their Forecasts On Merit Medical Systems After Strong Q2 Results

Merit Medical Systems Inc (NASDAQ: MMSI) reported strong Q2 earnings, beating estimates with raised guidance. Analysts maintain Buy ratings with increased price targets.

Avi Kapoor

PRO
Merit Medical Systems Raises FY2026 Adj EPS Guidance from $4.01-$4.15 to $4.25-$4.35 vs $4.07 Est; Raises FY2026 Sales Guidance from $1.612B-$1.634B to $1.631B-$1.643B vs $1.620B Est

Merit Medical Systems (NASDAQ:MMSI) raises FY2026 Adj EPS guidance from $4.01-$4.15 to $4.25-$4.35 vs $4.07 analyst estimate. Raises FY2026 sales outlook from $1.612 billion-$1.634 billion to $1.631 billion-$1.643

Benzinga Newsdesk

PRO
Merit Medical Systems Q2 Adj. EPS $1.19 Beats $0.96 Estimate, Sales $418.843M Beat $405.268M Estimate

Benzinga Newsdesk

PRO
Merit Medical Systems Affirms FY2026 Adj EPS Guidance of $4.01-$4.15 vs $4.03 Est; Raises FY2026 Sales Guidance from $1.610B-$1.630B to $1.612B-$1.634B vs $1.619B Est

Merit Medical Systems (NASDAQ:MMSI) affirms FY2026 Adj EPS guidance from $4.01-$4.15 to $4.01-$4.15 vs $4.03 analyst estimate. Raises FY2026 sales outlook from $1.610 billion-$1.630 billion to $1.612 billion-$1.634

Benzinga Newsdesk

PRO
Merit Medical Systems Q1 Adj. EPS $0.94 Beats $0.83 Estimate, Sales $381.877M Beat $377.632M Estimate

Merit Medical Systems (NASDAQ:MMSI) reported quarterly earnings of $0.94 per share which beat the analyst consensus estimate of $0.83 by 13.25 percent. This is a 9.3 percent increase over earnings of $0.86 per share from

Benzinga Newsdesk

Earnings Scheduled For April 30, 2026

Benzinga Insights

Merit Medical Systems Inc